Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib

ConclusionsRosiglitazone combined with olaparib can help manage ovarian cancer by ameliorating olaparib-induced senescence and improving anti-tumor effects.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research